BriaCell Therapeutics Corp.

Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.

BCTX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Website:: https://briacell.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing targeted cellular immunotherapies to activate the patient's immune system against cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™ has received FDA Fast Track designation and has shown efficacy in heavily pre-treated patients, including those with central nervous system metastases. The company is also advancing its next-generation Bria-OTS™ platform, which provides personalized, off-the-shelf treatments matched to a patient's HLA type. The Bria-OTS™ platform is being evaluated in a Phase 1/2 clinical trial for multiple cancers, including breast, prostate, and lung cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BriaCell Therapeutics Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BriaCell Therapeutics Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BriaCell Therapeutics Corp. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Eezy Oyj HR services firm for the full employment lifecycle, from recruitment to freelancer support.	Finland	EEZY
Elicio Therapeutics, Inc. Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.	United States of America	ELTX
enCore Energy Corp. American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.	United States of America	EU
ENERGY FUELS INC A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.	United States of America	UUUU
ENIGMATIG LTD Global expansion and regulatory compliance consultancy for the financial services industry.	United States of America	EGG
Enjin Co., Ltd. PR firm for SMEs and medical institutions, offering consulting and a media matching platform.	Japan	7370
Ensol Biosciences Inc. Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.	South Korea	140610
Enveric Biosciences, Inc. Develops novel neuroplastogen drugs for severe mental health and addiction disorders.	United States of America	ENVB
Eutilex Co.,Ltd. Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.	South Korea	263050
Evaxion A/S Develops AI-powered, personalized vaccines for cancer and infectious diseases.	United States of America	EVAX